These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 21415069)

  • 1. Plasma renin activity predicts cardiovascular mortality in the Heart Outcomes Prevention Evaluation (HOPE) study.
    Verma S; Gupta M; Holmes DT; Xu L; Teoh H; Gupta S; Yusuf S; Lonn EM
    Eur Heart J; 2011 Sep; 32(17):2135-42. PubMed ID: 21415069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of plasma renin activity in heart failure.
    Vergaro G; Emdin M; Iervasi A; Zyw L; Gabutti A; Poletti R; Mammini C; Giannoni A; Fontana M; Passino C
    Am J Cardiol; 2011 Jul; 108(2):246-51. PubMed ID: 21545993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of myocardial infarction by N-terminal-pro-B-type natriuretic peptide, C-reactive protein, and renin in subjects with cerebrovascular disease.
    Campbell DJ; Woodward M; Chalmers JP; Colman SA; Jenkins AJ; Kemp BE; Neal BC; Patel A; MacMahon SW
    Circulation; 2005 Jul; 112(1):110-6. PubMed ID: 15983245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of plasma renin with 10-year cardiovascular mortality, sudden cardiac death, and death due to heart failure.
    Tomaschitz A; Pilz S; Ritz E; Morganti A; Grammer T; Amrein K; Boehm BO; März W
    Eur Heart J; 2011 Nov; 32(21):2642-9. PubMed ID: 21606079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic significance of bundle branch block in high-risk chronic stable vascular disease patients: a report from the HOPE trial.
    Sumner G; Salehian O; Yi Q; Healey J; Mathew J; Al-Merri K; Al-Nemer K; Mann JF; Dagenais G; Lonn E;
    J Cardiovasc Electrophysiol; 2009 Jul; 20(7):781-7. PubMed ID: 19298567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is plasma renin activity a biomarker for the prediction of renal and cardiovascular outcomes in treated hypertensive patients? Observations from the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
    Sever PS; Chang CL; Prescott MF; Gupta A; Poulter NR; Whitehouse A; Scanlon M
    Eur Heart J; 2012 Dec; 33(23):2970-9. PubMed ID: 22942337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease.
    Kragelund C; Grønning B; Køber L; Hildebrandt P; Steffensen R
    N Engl J Med; 2005 Feb; 352(7):666-75. PubMed ID: 15716560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative impact of multiple biomarkers and N-Terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study.
    Blankenberg S; McQueen MJ; Smieja M; Pogue J; Balion C; Lonn E; Rupprecht HJ; Bickel C; Tiret L; Cambien F; Gerstein H; Münzel T; Yusuf S;
    Circulation; 2006 Jul; 114(3):201-8. PubMed ID: 16831981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
    Sabatine MS; Morrow DA; Jablonski KA; Rice MM; Warnica JW; Domanski MJ; Hsia J; Gersh BJ; Rifai N; Ridker PM; Pfeffer MA; Braunwald E;
    Circulation; 2007 Mar; 115(12):1528-36. PubMed ID: 17372173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes and the HOPE study: implications for macrovascular and microvascular disease.
    Gerstein HC
    Int J Clin Pract Suppl; 2001 Jan; (117):8-12. PubMed ID: 11715357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher plasma renin activity is a risk factor for total mortality in older Japanese individuals: the Takahata study.
    Daimon M; Konta T; Oizumi T; Karasawa S; Kaino W; Takase K; Jimbu Y; Wada K; Kameda W; Susa S; Saito T; Kubota I; Kayama T; Kato T
    Metabolism; 2012 Apr; 61(4):504-11. PubMed ID: 22001336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD40 ligand and risk of ischemic stroke or coronary events in patients with chronic coronary heart disease.
    Tanne D; Haim M; Goldbourt U; Boyko V; Reshef T; Adler Y; Benderly M; Mekori YA; Behar S
    Int J Cardiol; 2006 Mar; 107(3):322-6. PubMed ID: 16503253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.
    Manzano-Fernández S; Boronat-Garcia M; Albaladejo-Otón MD; Pastor P; Garrido IP; Pastor-Pérez FJ; Martínez-Hernández P; Valdés M; Pascual-Figal DA
    Am J Cardiol; 2009 Jun; 103(12):1753-9. PubMed ID: 19539088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated plasma renin activity predicts adverse outcome in chronic heart failure, independently of pharmacologic therapy: data from the Valsartan Heart Failure Trial (Val-HeFT).
    Masson S; Solomon S; Angelici L; Latini R; Anand IS; Prescott M; Maggioni AP; Tognoni G; Cohn JN;
    J Card Fail; 2010 Dec; 16(12):964-70. PubMed ID: 21111986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of heart rate at rest as a predictor of mortality, hospitalization for heart failure, myocardial infarction, and stroke in patients with stable coronary heart disease (Data from the Treating to New Targets [TNT] trial).
    Ho JE; Bittner V; Demicco DA; Breazna A; Deedwania PC; Waters DD
    Am J Cardiol; 2010 Apr; 105(7):905-11. PubMed ID: 20346304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of N-terminal fragment of brain natriuretic peptide and tissue inhibitor of metalloproteinase-1 levels as predictors of cardiovascular outcome in the LIPID study.
    West MJ; Nestel PJ; Kirby AC; Schnabel R; Sullivan D; Simes RJ; Pollicino C; Lubos E; Münzel TF; White HD; Tonkin AM; Bickel C; Tiret L; Blankenberg S;
    Eur Heart J; 2008 Apr; 29(7):923-31. PubMed ID: 18296678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High plasma N-terminal pro-brain natriuretic peptide level found in diabetic patients after myocardial infarction is associated with an increased risk of in-hospital mortality and cardiogenic shock.
    Vergès B; Zeller M; Desgrès J; Dentan G; Laurent Y; Janin-Manificat L; L'Huillier I; Rioufol G; Beer JC; Makki H; Rochette L; Gambert P; Cottin Y
    Eur Heart J; 2005 Sep; 26(17):1734-41. PubMed ID: 15831555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of Type 2 diabetes and microalbuminuria on future cardiovascular events in patients with clinically manifest vascular disease from the Second Manifestations of ARTerial disease (SMART) study.
    Soedamah-Muthu SS; Visseren FL; Algra A; van der Graaf Y;
    Diabet Med; 2008 Jan; 25(1):51-7. PubMed ID: 18199132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
    Grewal J; McKelvie RS; Persson H; Tait P; Carlsson J; Swedberg K; Ostergren J; Lonn E
    Am J Cardiol; 2008 Sep; 102(6):733-7. PubMed ID: 18773998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum parathyroid hormone and risk of adverse outcomes in patients with stable coronary heart disease.
    Grandi NC; Breitling LP; Hahmann H; Wüsten B; März W; Rothenbacher D; Brenner H
    Heart; 2011 Aug; 97(15):1215-21. PubMed ID: 21586795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.